Alternatives to DNA1

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI-powered blood test for early cancer detection and subtyping.

Unleashing the power of genomics at scale for biological advances and human health.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

Synthetic biology startup optimizing gene expression for food and biotech applications.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Global leader in serving science, providing analytical instruments, consumables, and services for research, diagnostics, and manufacturing.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

AI-driven digital twin of embryo development for cell-based therapies.

Life sciences data platform for deep-phenotype multi-omics datasets.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Advanced infectious disease diagnostics

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational biology platform for optimizing IVF success rates and reducing treatment burdens.

Develops a platform for individual drug customization using aptamers for cancer treatment.